{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:44:39Z","timestamp":1791297879190,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T00:00:00Z","timestamp":1422489600000},"content-version":"vor","delay-in-days":789,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIDDK, National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.bpg.2012.12.003","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T09:59:07Z","timestamp":1365587947000},"page":"737-753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":218,"title":["Pancreatic neuroendocrine tumors: Clinical features, diagnosis and medical treatment: Advances"],"prefix":"10.1016","volume":"26","author":[{"given":"Tetsuhide","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisato","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2012.12.003_bib1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/j.seminoncol.2010.10.014","article-title":"Pancreatic endocrine tumors","volume":"37","author":"Oberg","year":"2010","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bpg.2012.12.003_bib2","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1053\/j.gastro.2008.05.047","article-title":"Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors","volume":"135","author":"Metz","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.12.003_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00535-012-0642-8","article-title":"Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances","volume":"47","author":"Ito","year":"2012","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.12.003_bib4","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000335591","article-title":"ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes","volume":"95","author":"Jensen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bpg.2012.12.003_bib5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/MPA.0b013e3181ebb168","article-title":"NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas","volume":"39","author":"Kulke","year":"2010","journal-title":"Pancreas"},{"issue":"Suppl. 1","key":"10.1016\/j.bpg.2012.12.003_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1530\/ERC-11-0013","article-title":"Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms","volume":"18","author":"Kloppel","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bpg.2012.12.003_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","article-title":"ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary","volume":"95","author":"Pavel","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bpg.2012.12.003_bib8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.6004\/jnccn.2012.0075","article-title":"Neuroendocrine tumors","volume":"10","author":"Kulke","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.bpg.2012.12.003_bib9","first-page":"182","article-title":"Molecular pathology of pancreatic neuroendocrine tumors","volume":"3","author":"Chen","year":"2012","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.bpg.2012.12.003_bib10","first-page":"794","article-title":"Surgical management of neuroendocrine tumors of the gastrointestinal tract","volume":"25","author":"Huang","year":"2011","journal-title":"Oncol (Williston Park)"},{"key":"10.1016\/j.bpg.2012.12.003_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000335587","article-title":"ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors","volume":"95","author":"Falconi","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bpg.2012.12.003_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.bpg.2012.12.003_bib13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/0016-5085(90)90459-E","article-title":"Multiple hormone elevations in patients with Zollinger\u2013Ellison syndrome: prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome","volume":"99","author":"Chiang","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.12.003_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000225948","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers","volume":"90","author":"O'Toole","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bpg.2012.12.003_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/02841868909111209","article-title":"Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients","volume":"28","author":"Eriksson","year":"1989","journal-title":"Acta Oncol"},{"key":"10.1016\/j.bpg.2012.12.003_bib16","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2004.10.031","article-title":"Paraneoplastic syndromes in cancer: case 1. Polycythemia as a result of ectopic erythropoietin production in metastatic pancreatic carcinoid tumor","volume":"22","author":"Samyn","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpg.2012.12.003_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM198210143071606","article-title":"Hypertension associated with a renin-secreting adenocarcinoma of the pancreas","volume":"307","author":"Ruddy","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2012.12.003_bib18","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1210\/jc.2011-2005","article-title":"GLP-1 and glucagon secretion from a pancreatic neuroendocrine tumor causing diabetes and hyperinsulinemic hypoglycemia","volume":"97","author":"Roberts","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2012.12.003_bib19","article-title":"Hypoglycemia associated with the production of insulin-like growth factor II in a pancreatic islet cell tumor: a case report","author":"Chung","year":"2008","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.bpg.2012.12.003_bib20","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1210\/jc.2003-032029","article-title":"Ectopic bioactive luteinizing hormone secretion by a pancreatic endocrine tumor, manifested as luteinized granulosa-thecal cell tumor of the ovaries","volume":"90","author":"Piaditis","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2012.12.003_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF03351063","article-title":"Ectopic secretion of LH by an endocrine pancreatic tumor","volume":"27","author":"Brignardello","year":"2004","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.bpg.2012.12.003_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000051874","article-title":"Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1-, GLP-2- and PYY-producing neuroendocrine carcinoma","volume":"63","author":"Byrne","year":"2001","journal-title":"Digestion"},{"key":"10.1016\/j.bpg.2012.12.003_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/gut.25.7.784","article-title":"Glucagonoma syndrome demonstrating giant duodenal villi","volume":"25","author":"Stevens","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2012.12.003_bib24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/gut.13.7.520","article-title":"An enteroglucagon tumour","volume":"13","author":"Bloom","year":"1972","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2012.12.003_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1752-1947-4-178","article-title":"Duodenal enteroglucagonoma revealed by differential comparison of serum and tissue glucagon reactivity with siemens' double glucagon antibody and dakocytomation's polyclonal rabbit anti-human glucagon: a case report","volume":"4","author":"Vanderlan","year":"2010","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.bpg.2012.12.003_bib26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00006676-199805000-00014","article-title":"Calcitonin-secreting tumors of the pancreas: about six cases","volume":"16","author":"Fleury","year":"1998","journal-title":"Pancreas"},{"key":"10.1016\/j.bpg.2012.12.003_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MPA.0b013e3182015f5d","article-title":"Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity","volume":"40","author":"Schneider","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.bpg.2012.12.003_bib28","first-page":"263","article-title":"Somatostatinomas, PPomas, neurotensinomas","volume":"14","author":"Vinik","year":"1987","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bpg.2012.12.003_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000142739","article-title":"A pancreatic polypeptide-producing pancreatic tumor causing WDHA syndrome","volume":"2","author":"Amrilleva","year":"2008","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.bpg.2012.12.003_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3109\/00365527809181786","article-title":"A pancreatic-polypeptide-producing tumour associated with the WDHA syndrome","volume":"13","author":"Lundqvist","year":"1978","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.12.003_bib31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archsurg.1984.01390170008003","article-title":"Pancreatic polypeptide-producing tumors. Silent lesions of the pancreas?","volume":"119","author":"Strodel","year":"1984","journal-title":"Arch Surg"},{"key":"10.1016\/j.bpg.2012.12.003_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12031-007-0004-9","article-title":"Elevated serum ghrelin exerts an orexigenic effect that may maintain body mass index in patients with metastatic neuroendocrine tumors","volume":"33","author":"Wang","year":"2007","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.bpg.2012.12.003_bib33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-09-0073","article-title":"Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases","volume":"161","author":"Walter","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bpg.2012.12.003_bib34","first-page":"156","article-title":"Overview of chronic diarrhea caused by functional neuroendocrine neoplasms","volume":"10","author":"Jensen","year":"1999","journal-title":"Semin Gastrointest Dis"},{"key":"10.1016\/j.bpg.2012.12.003_bib35","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10552-010-9512-y","article-title":"Incidence rates of exocrine and endocrine pancreatic cancers in the United States","volume":"21","author":"Zhou","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bpg.2012.12.003_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00535-009-0194-8","article-title":"Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan","volume":"45","author":"Ito","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.12.003_bib37","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1111\/j.1572-0241.2003.07704.x","article-title":"Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study","volume":"98","author":"Gullo","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.12.003_bib38","series-title":"Recent advances in pathophysiology and management of inflammatory bowel diseases and digestive endocrine tumors","first-page":"192","article-title":"Natural history of digestive endocrine tumors","author":"Jensen","year":"1999"},{"key":"10.1016\/j.bpg.2012.12.003_bib39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.sla.0000143252.02142.3e","article-title":"Resolved and unresolved controversies in the surgical management of patients with Zollinger\u2013Ellison syndrome","volume":"240","author":"Norton","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2012.12.003_bib40","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.dld.2003.11.024","article-title":"Diagnostic uses of radiolabelled somatostatin-receptor analogues in gastroenteropancreatic endocrine tumors","volume":"36","author":"Gibril","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2012.12.003_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.rcl.2011.02.011","article-title":"Imaging of neuroendocrine tumors","volume":"49","author":"Heller","year":"2011","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.bpg.2012.12.003_bib42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2214\/ajr.143.3.585","article-title":"Localization of islet cell tumors by dynamic CT: comparison with plain CT, arteriography, sonography and venous sampling","volume":"143","author":"Krudy","year":"1984","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.bpg.2012.12.003_bib43","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7326\/0003-4819-105-6-841","article-title":"Selective venous sampling for gastrin to localize gastrinomas. A prospective study","volume":"105","author":"Cherner","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2012.12.003_bib44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1148\/radiology.174.1.2294556","article-title":"Gastrinomas: localization by means of selective intraarterial injection of secretin","volume":"174","author":"Doppman","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.bpg.2012.12.003_bib45","first-page":"276","article-title":"Arterial stimulation and venous sampling for glucagonomas of the pancreas","volume":"59","author":"Eguchi","year":"2011","journal-title":"Hepatogastroenterology"},{"issue":"Suppl. 7","key":"10.1016\/j.bpg.2012.12.003_bib46","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management and controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bpg.2012.12.003_bib47","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/jc.2002-021314","article-title":"Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1","volume":"88","author":"Gibril","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2012.12.003_bib48","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-0938-3","article-title":"Meningiomas may be a component tumor of MEN1","volume":"10","author":"Asgharian","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpg.2012.12.003_bib49","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0002-9440(10)61788-9","article-title":"Multiple leiomyomas of the esophagus, lung, and uterus in multiple endocrine neoplasia type 1","volume":"159","author":"McKeeby","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bpg.2012.12.003_bib50","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1210\/jc.2004-0218","article-title":"Cutaneous tumors in patients with MEN1 and gastrinomas: prospective study of frequency and development of criteria with high sensitivity and specificity","volume":"89","author":"Asgharian","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2012.12.003_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger\u2013Ellison syndrome. A prospective study of 107 cases and comparison with 1009 patients from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bpg.2012.12.003_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00005792-200011000-00004","article-title":"Zollinger-Ellison syndrome: clinical presentation in 261 patients","volume":"79","author":"Roy","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bpg.2012.12.003_bib53","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.3748\/wjg.v12.i34.5440","article-title":"Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features","volume":"12","author":"Anlauf","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.12.003_bib54","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM199003153221103","article-title":"Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger\u2013Ellison syndrome","volume":"322","author":"Pipeleers-Marichal","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2012.12.003_bib55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000105810","article-title":"Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance","volume":"74","author":"Anlauf","year":"2007","journal-title":"Pathobiology"},{"key":"10.1016\/j.bpg.2012.12.003_bib56","first-page":"1086","article-title":"Location, incidence and malignant potential of duodenal gastrinomas","volume":"110","author":"Thom","year":"1991","journal-title":"Surgery"},{"key":"10.1016\/j.bpg.2012.12.003_bib57","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.sla.0000124290.05524.5e","article-title":"Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases or survival in patients with Zollinger\u2013Ellison syndrome (ZES)?","volume":"239","author":"Norton","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2012.12.003_bib58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2796.1998.00281.x","article-title":"Management of the Zollinger\u2013Ellison syndrome in patients with multiple endocrine neoplasia type 1","volume":"243","author":"Jensen","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.bpg.2012.12.003_bib59","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel\u2013Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2012.12.003_bib60","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/gast.2000.18143","article-title":"Pancreatic involvement in von Hippel\u2013Lindau disease","volume":"119","author":"Hammel","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.12.003_bib61","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1067\/msy.2000.110239","article-title":"Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel\u2013Lindau disease","volume":"128","author":"Libutti","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.bpg.2012.12.003_bib62","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bpg.2012.12.003_bib63","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bpg.2005.05.009","article-title":"Duodenal neuroendocrine tumors: classification, functional syndromes, diagnosis and medical treatment","volume":"19","author":"Hoffmann","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2012.12.003_bib64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jso.2930590116","article-title":"Von Recklinghausen's disease associated with duodenal somatostatinoma: contrast of duodenal versus pancreatic somatostatinomas","volume":"59","author":"Mao","year":"1995","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.bpg.2012.12.003_bib65","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2012.12.003_bib66","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/MPA.0b013e3181b2bb03","article-title":"Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor","volume":"38","author":"Zhou","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.bpg.2012.12.003_bib67","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.endonu.2012.06.006","article-title":"Glucagon receptor is required for long-term survival: a natural history study of the Mahvash disease in a murine model","volume":"59","author":"Yu","year":"2012","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.bpg.2012.12.003_bib68","first-page":"597","article-title":"Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases","volume":"75","author":"Stefanini","year":"1974","journal-title":"Surgery"},{"key":"10.1016\/j.bpg.2012.12.003_bib69","series-title":"Sleisenger and Fordtran's gastrointestinal and liver disease","first-page":"491","article-title":"Endocrine tumors of the pancreas and gastrointestinal tract","author":"Jensen","year":"2010"},{"key":"10.1016\/j.bpg.2012.12.003_bib70","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2005.05.008","article-title":"Insulinoma","volume":"19","author":"Grant","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2012.12.003_bib71","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00125-010-1798-5","article-title":"Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986\u20132006 in Sweden","volume":"53","author":"Marsk","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpg.2012.12.003_bib72","first-page":"1582","article-title":"Noninsulinoma pancreatogenous hypoglycemia:a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes","volume":"84","author":"Service","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2012.12.003_bib73","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an endocrine society clinical practice guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2012.12.003_bib74","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/BF01655532","article-title":"Diazoxide in the management of patients with insulinoma","volume":"10","author":"Goode","year":"1986","journal-title":"World J Surg"},{"key":"10.1016\/j.bpg.2012.12.003_bib75","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/pgmj.73.864.640","article-title":"Diazoxide treatment for insulinoma: a national UK survey","volume":"73","author":"Gill","year":"1997","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.bpg.2012.12.003_bib76","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/eje.1.01901","article-title":"Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies","volume":"152","author":"Vezzosi","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bpg.2012.12.003_bib77","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1056\/NEJMc0806740","article-title":"Glycemic control in patients with insulinoma treated with everolimus","volume":"360","author":"Kulke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2012.12.003_bib78","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1634\/theoncologist.2010-0222","article-title":"Everolimus induces rapid plasma glucose normalization in insulinoma patients by effects on tumor as well as normal tissues","volume":"16","author":"Fiebrich","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.bpg.2012.12.003_bib79","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.gie.2011.09.019","article-title":"US-guided ethanol ablation of insulinomas: a new treatment option","volume":"75","author":"Levy","year":"2012","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2012.12.003_bib80","first-page":"189","article-title":"Gastric secretion in Zollinger\u2013Ellison syndrome: correlation with clinical expression, tumor extent and role in diagnosis - a prospective NIH study of 235 patients and review of the literature in 984 cases","volume":"80","author":"Roy","year":"2001","journal-title":"Medicine(Baltimore)"},{"key":"10.1016\/j.bpg.2012.12.003_bib81","first-page":"555","article-title":"Gastrointestinal endocrine tumors. Gastrinoma","volume":"10","author":"Jensen","year":"1996","journal-title":"Bailliere's Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2012.12.003_bib82","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000098009","article-title":"Gastrinoma (duodenal and pancreatic)","volume":"84","author":"Jensen","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bpg.2012.12.003_bib83","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0002-9343(94)90323-9","article-title":"Zollinger\u2013Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1","volume":"97","author":"Benya","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.bpg.2012.12.003_bib84","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","article-title":"Prospective study of surgery for primary hyperaparathyroidism (HPT) in multiple endocrine neoplasia type 1 (MEN1), and Zollinger\u2013Ellison syndrome (ZES): longterm outcome of a more virulent form of HPT","volume":"247","author":"Norton","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2012.12.003_bib85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.md.0000236956.74128.76","article-title":"Serum gastrin in Zollinger\u2013Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature","volume":"85","author":"Berna","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bpg.2012.12.003_bib86","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.3748\/wjg.v18.i39.5495","article-title":"Diagnosis of Zollinger\u2013Ellison syndrome: increasingly difficult","volume":"18","author":"Ito","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2012.12.003_bib87","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cgh.2011.07.012","article-title":"Diagnosis of the Zollinger\u2013Ellison syndrome","volume":"10","author":"Metz","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2012.12.003_bib88","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/MD.0b013e31802b518c","volume":"85","author":"Berna","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bpg.2012.12.003_bib89","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1046\/j.1365-2036.2001.01085.x","article-title":"Does the widespread use of proton pump inhibitors mask, complicate and\/or delay the diagnosis of Zollinger\u2013Ellison syndrome?","volume":"15","author":"Corleto","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2012.12.003_bib90","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/00365510701771831","article-title":"The art of measuring gastrin in plasma: a dwindling diagnostic discipline?","volume":"68","author":"Rehfeld","year":"2008","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.bpg.2012.12.003_bib91","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cgh.2011.08.012","article-title":"The Zollinger\u2013Ellison syndrome: dangers and consequences of interrupting antisecretory treatment","volume":"10","author":"Poitras","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2012.12.003_bib92","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-119-3-199308010-00004","article-title":"Assessment and prediction of long-term cure in patients with Zollinger\u2013Ellison syndrome: the best approach","volume":"119","author":"Fishbeyn","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2012.12.003_bib93","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/0016-5085(88)90670-1","article-title":"Prospective study of chemotherapy in patients with metastatic gastrinoma","volume":"94","author":"von Schrenck","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.12.003_bib94","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/14656566.2013.767332","article-title":"Pharmacotherapy of Zollinger\u2013Ellison syndrome","volume":"14","author":"Ito","year":"2013","journal-title":"Expert Opin Pharmacotherapy"},{"key":"10.1016\/j.bpg.2012.12.003_bib95","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/0016-5085(92)91170-9","article-title":"Currently used doses of omeprazole in Zollinger\u2013Ellison syndrome are too high","volume":"103","author":"Metz","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.12.003_bib96","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9343(98)00087-4","article-title":"Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger\u2013Ellison syndrome","volume":"104","author":"Termanini","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.bpg.2012.12.003_bib97","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11894-010-0141-0","article-title":"Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin b (12), iron, and magnesium","volume":"12","author":"Ito","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.bpg.2012.12.003_bib98","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1742-7843.2006.pto_378.x","article-title":"Consequences of long-term proton pump blockade: highlighting insights from studies of patients with gastrinomas","volume":"98","author":"Jensen","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.bpg.2012.12.003_bib99","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1210\/jc.2007-2279","article-title":"A prospective study of gastric carcinoids and enterochromaffin-like cells changes in multiple endocrine neoplaisa type 1 and Zollinger\u2013Ellison syndrome: identification of risk factors","volume":"93","author":"Berna","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2012.12.003_bib100","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0016-5085(90)90611-4","article-title":"The effect of Zollinger\u2013Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells","volume":"99","author":"Maton","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.12.003_bib101","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0016-5085(00)70139-9","article-title":"Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger\u2013Ellison syndrome","volume":"118","author":"Lew","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2012.12.003_bib102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/EJE-12-0117","article-title":"MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly","volume":"167","author":"Filopanti","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bpg.2012.12.003_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198607033150101","article-title":"Cushing's syndrome in patients with Zollinger\u2013Ellison syndrome","volume":"315","author":"Maton","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2012.12.003_bib104","first-page":"1259","article-title":"VIPomas: an update in diagnosis and management in a series of 11 patients","volume":"52","author":"Nikou","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.bpg.2012.12.003_bib105","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4065\/71.11.1030","article-title":"Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors","volume":"71","author":"Wermers","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bpg.2012.12.003_bib106","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2265.2011.03967.x","article-title":"Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour","volume":"74","author":"Eldor","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.bpg.2012.12.003_bib107","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1440-1746.2007.05053.x","article-title":"Somatostatinoma: clinico-pathological features of three cases and literature reviewed","volume":"23","author":"Nesi","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2012.12.003_bib108","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1210\/jc.2011-2930","article-title":"Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases","volume":"97","author":"Garby","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bpg.2012.12.003_bib109","first-page":"675","article-title":"Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome","volume":"85","author":"Larsson","year":"1976","journal-title":"Am J Pathol"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691813000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691813000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T05:50:10Z","timestamp":1562910610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691813000292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":109,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1521691813000292"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2012.12.003","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatic neuroendocrine tumors: Clinical features, diagnosis and medical treatment: Advances","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2012.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}